Lianan Medical Showcases Newly Upgraded Electronic Colposcope at 2026 Shenzhen Cervicoscopy and Cervical Pathology Conference
The 2026 Shenzhen Cervicoscopy and Cervical Pathology Conference, hosted by Peking University Shenzhen Hospital, has successfully concluded. Focusing on technological innovations in colposcopic diagnosis, standardized diagnosis and treatment of cervical pathology, and cutting-edge clinical application research, the conference gathered authoritative experts and frontline medical practitioners in obstetrics, gynecology and cervical pathology from Shenzhen and surrounding areas, building a high-end platform for academic exchanges and technical exhibitions. As an invited exhibitor, Lianan Medical showcased its fully upgraded electronic colposcope. Boasting optimized performance and innovative advantages, the product won wide recognition and high praise from industry experts and clinical physicians on site.
Centering on practical clinical needs, this academic event is committed to promoting standardized, intelligent and precise diagnosis and treatment solutions for cervical diseases, and advancing the overall development of cervical disease screening and treatment in the region. As a professional enterprise focusing on the R&D, production and innovation of gynecological diagnosis and treatment equipment, Lianan Medical actively participated in the grand event with its flagship electronic colposcope. Equipped with newly upgraded technologies independently developed by the company’s engineering team, the exhibited product achieves comprehensive improvements in equipment performance, clinical adaptability and intelligent experience.
At the exhibition site, the technical team of Lianan Medical provided professional on-site operation demonstrations and technical explanations, fully presenting the diagnostic advantages and core features of the equipment, which attracted numerous participating experts and clinical medical staff to stop for observation and in-depth communication. Compared with traditional devices, the newly upgraded electronic colposcope conforms to the current development trend of precise cervical disease diagnosis, effectively addresses various clinical pain points. It features simpler operation, higher-quality imaging and stronger clinical applicability, fully adapting to diverse scenarios including routine diagnosis, large-scale screening, scientific research and teaching in medical institutions at all levels.
Industry insiders attending the exhibition commented that the equipment upgrade of Lianan Medical is highly practical, closely catering to clinical demands and industry development trends, and provides a superior domestic equipment solution for the precise diagnosis of cervical diseases. Many participating physicians took the initiative to inquire about product details, clinical adaptation schemes and relevant cooperation opportunities. The lively on-site communication has laid a solid foundation for the company’s subsequent in-depth clinical cooperation and technology implementation.
With years of dedication to the gynecological medical device industry, Lianan Medical has always adhered to the philosophy of integrating medicine with engineering and empowering medical development through innovation. Focusing on clinical pain points and industry frontiers, the company continuously optimizes core products and iterates innovative technologies. The participation in this high-level municipal cervical pathology academic conference fully demonstrates Lianan Medical’s independent R&D strength and product innovation capability, and enables the enterprise to connect with cutting-edge industry concepts and frontline clinical demands through a professional academic platform.
In the future, Lianan Medical will continue to deepen its layout in the field of precise gynecological diagnosis and treatment. Centering on clinical needs, the company will keep promoting technological innovation and performance optimization of products, develop higher-quality and more intelligent domestic medical devices, facilitate the standardized and precise development of regional cervical disease diagnosis and treatment, and inject innovative momentum into the high-quality development of maternal and child health care.